Hydroxychloroquine vs Nivolumab
Hydroxychloroquine vs Nivolumab: Overview
This comparison examines the pharmacological differences between Hydroxychloroquine and Nivolumab.
Mechanism of Action
Hydroxychloroquine: Accumulates in lysosomes raising pH; inhibits toll-like receptor signaling.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Hydroxychloroquine β 40-50 days; Nivolumab β 27 days.
Chemical Properties
Molecular Formula: Hydroxychloroquine β C18H26ClN3O.
Molecular Weight: Hydroxychloroquine β 335.8720 g/mol.
Type: Hydroxychloroquine β Small molecule; Nivolumab β Antibody.